Clinical Trials for Arcutis Biotherapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Arcutis Biotherapeutics

Clinical Trials (3)

NCT07077902
A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa
PHASE2Not yet recruiting
10 participants
Started: Sep 30, 2025 · Completed: Sep 30, 2026
1 condition2 sponsors4 locations
NCT07105254
An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV)
PHASE2Recruiting
20 participants
Started: Aug 1, 2025 · Completed: Jun 15, 2026
1 condition2 sponsors1 location
NCT06998056
Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis
PHASE2Recruiting
100 participants
Started: Jun 9, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor13 locations